CA2189435A1 - Dihydro ou tetrahydroporphyrines derivees du polyethyleneglycol, leur preparation et leur utilisation en tant que composes de photosensibilisation servant a localiser des tumeurs - Google Patents
Dihydro ou tetrahydroporphyrines derivees du polyethyleneglycol, leur preparation et leur utilisation en tant que composes de photosensibilisation servant a localiser des tumeursInfo
- Publication number
- CA2189435A1 CA2189435A1 CA002189435A CA2189435A CA2189435A1 CA 2189435 A1 CA2189435 A1 CA 2189435A1 CA 002189435 A CA002189435 A CA 002189435A CA 2189435 A CA2189435 A CA 2189435A CA 2189435 A1 CA2189435 A1 CA 2189435A1
- Authority
- CA
- Canada
- Prior art keywords
- compounds
- tumour
- group
- derivatised
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Ces composés sont des dihydro ou tétrahydroporphorines dérivées du polyéthylèneglycol, acceptables sur le plan pharmacologique, servant à localiser des tumeurs et répondant aux formules (4), (5) et (6) dans lesquelles R?1¿¿n? peut représenter -OH mais, dans au moins deux cas, représente une chaîne de formule (-O-X¿p?-[CH¿2?CH¿2?O]¿m?-Y)¿n? dans laquelle n vaut 1 à 3, m vaut 5 à 250 et p vaut 0 à 1; le groupe Y peut représenter un groupe acyle ou alcoyle C¿1-12? mais représente, de préférence, un groupe méthyle; le groupe de liaison X peut être présent ou absent, mais s'il est présent, il peut représenter l'une des formes suivantes: R?2¿ = -(C=O)-(CH¿2?)¿q?-O- où q vaut 1 à 5, R?3¿ = -CH¿2?-CH(OH)-(CH¿2?)¿s?-O- où s vaut 1 à 4, R?4¿ = -(C=O)-(CH¿2?)¿t?-(C=O)-O- où t vaut 1 à 4. Ces composés de photosensibilisation à substitution polyéther permettent de mieux localiser les tumeurs grâce à leur pénétration plus efficace à l'intérieur des cellules tumorales. Des doses globalement inférieures de médicament permettent d'améliorer le profil d'effets secondaires du traitement, notamment en égard à la photosensibilisation de la peau.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9408746.7 | 1994-05-03 | ||
GB9408746A GB9408746D0 (en) | 1994-05-03 | 1994-05-03 | Tumour locallising photosensitising compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2189435A1 true CA2189435A1 (fr) | 1995-11-09 |
Family
ID=10754481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002189435A Abandoned CA2189435A1 (fr) | 1994-05-03 | 1995-05-02 | Dihydro ou tetrahydroporphyrines derivees du polyethyleneglycol, leur preparation et leur utilisation en tant que composes de photosensibilisation servant a localiser des tumeurs |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0758331A1 (fr) |
JP (1) | JPH09512544A (fr) |
KR (1) | KR970702862A (fr) |
AU (1) | AU2317295A (fr) |
CA (1) | CA2189435A1 (fr) |
GB (1) | GB9408746D0 (fr) |
NO (1) | NO964635L (fr) |
NZ (1) | NZ284552A (fr) |
TW (1) | TW397836B (fr) |
WO (1) | WO1995029915A1 (fr) |
ZA (1) | ZA953560B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6362175B1 (en) * | 1991-09-20 | 2002-03-26 | The Trustees Of The University Of Pennsylvania | Porphyrin compounds for imaging tissue oxygen |
DE19514087A1 (de) * | 1995-04-13 | 1996-10-17 | Deutsches Krebsforsch | Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein |
DE19627164C2 (de) * | 1996-07-05 | 1998-09-24 | Deutsches Krebsforsch | Herstellung polyether-aufweisender Chlorine und Bakteriochlorine, solche Verbindungen und ihre Verwendung |
ES2237146T3 (es) | 1998-08-28 | 2005-07-16 | Destiny Pharma Limited | Derivados de porfirina, su uso en terapia fotodinamica y dispositivos medicos que los contienen. |
GB0005855D0 (en) * | 2000-03-10 | 2000-05-03 | Scotia Holdings Plc | Compounds for pdt |
JP5000050B2 (ja) * | 2001-08-31 | 2012-08-15 | 浩 前田 | 抗腫瘍剤及びその製造方法 |
CN108715591B (zh) * | 2018-06-01 | 2021-04-13 | 华东理工大学 | 用作光敏剂的近红外吸收卟啉化合物及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8429845D0 (en) * | 1984-11-26 | 1985-01-03 | Efamol Ltd | Porphyrins & cancer treatment |
GB8805849D0 (en) * | 1988-03-11 | 1988-04-13 | Efamol Holdings | Porphyrins & cancer treatment |
ATE115864T1 (de) * | 1990-05-30 | 1995-01-15 | Deutsches Krebsforsch | Polyethersubstituierte tumormittel. |
-
1994
- 1994-05-03 GB GB9408746A patent/GB9408746D0/en active Pending
-
1995
- 1995-05-02 CA CA002189435A patent/CA2189435A1/fr not_active Abandoned
- 1995-05-02 NZ NZ284552A patent/NZ284552A/en unknown
- 1995-05-02 AU AU23172/95A patent/AU2317295A/en not_active Abandoned
- 1995-05-02 WO PCT/GB1995/000998 patent/WO1995029915A1/fr not_active Application Discontinuation
- 1995-05-02 JP JP7528083A patent/JPH09512544A/ja active Pending
- 1995-05-02 EP EP95916810A patent/EP0758331A1/fr not_active Withdrawn
- 1995-05-03 ZA ZA953560A patent/ZA953560B/xx unknown
- 1995-06-06 TW TW084105690A patent/TW397836B/zh active
-
1996
- 1996-11-01 NO NO964635A patent/NO964635L/no unknown
- 1996-11-02 KR KR1019960706199A patent/KR970702862A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1995029915A1 (fr) | 1995-11-09 |
JPH09512544A (ja) | 1997-12-16 |
NZ284552A (en) | 1997-12-19 |
AU2317295A (en) | 1995-11-29 |
NO964635D0 (no) | 1996-11-01 |
TW397836B (en) | 2000-07-11 |
NO964635L (no) | 1996-11-01 |
KR970702862A (ko) | 1997-06-10 |
ZA953560B (en) | 1996-01-11 |
EP0758331A1 (fr) | 1997-02-19 |
GB9408746D0 (en) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Moan et al. | The main photosensitizing components of hematoporphyrin derivative | |
AU611774B2 (en) | 5,10,15,20-tetra(hydroxyphenyl) porphyrins in cancer treatment | |
Pandey et al. | Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy | |
EP0186962B1 (fr) | Porphyrines et traitement du cancer | |
AU664377B2 (en) | Porphycene compounds for photodynamic therapy | |
CN101102766B (zh) | 新型卟啉衍生物,尤其二氢卟酚和/或菌绿素及其在光动力学治疗中的应用 | |
AU682149B2 (en) | Production and use of imines of porphyrins | |
US5162519A (en) | Porphyrins and cancer treatment | |
CA2189435A1 (fr) | Dihydro ou tetrahydroporphyrines derivees du polyethyleneglycol, leur preparation et leur utilisation en tant que composes de photosensibilisation servant a localiser des tumeurs | |
US20090318370A1 (en) | Novel glycoconjugated chlorin derivatives and method of producing the same | |
Reuther et al. | Comparison of the in vivo efficiency of photofrin II‐, mTHPC‐, mTHPC‐PEG‐and mTHPCnPEG‐mediated PDT in a human xenografted head and neck carcinoma | |
EP1091742A1 (fr) | Photosensiblisant a l'indium, pour tpd | |
EP0256036A4 (fr) | Production et utilisation de purpurines, chlorines et de compositions contenant de la purpurine et de la chlorine. | |
US7319147B2 (en) | Porphyrins and related compounds | |
van Lier | New sensitizers for photodynamic therapy of cancer | |
CA3002695C (fr) | Derive d'hypocrelline amphiphile monosubstitue ou polysubstitue, son procede de preparation et ses utilisations | |
US4347249A (en) | Class of seco bis-indolic compounds which can be used as drugs and a process for the preparation thereof | |
John et al. | 2, 6-dibrominated 3, 5-distyrylBODIPYs as photosensitizer dyes for photodynamic antimicrobial chemotherapy | |
CN107935964B (zh) | 一种多取代近红外竹红菌素衍生物及其制备方法和应用 | |
Rydzkowski et al. | Synthesis of new heterocyclic phenols: 8-hydroxy-imidazo [1, 2-a] pyridine | |
Kessel | HPD: structure and determinants of localization | |
AU761891B2 (en) | Indium photosensitizers for PDT | |
CA2245202A1 (fr) | Composes photosensibilisants localisant les tumeurs | |
JING et al. | First total synthesis of astechrome: novel hydroxamic acid with an indole-pyrazine skeleton | |
Krauss et al. | STUDIES ON PLANT BILE PIGMENTS—9. PHOTOOXIDATION OF A‐DIHYDROBILINDIONE AS PHYTOCHROME MODEL IN ACID MEDIUM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |